Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Park Ha Biological Technology Co., Ltd. ( (PHH) ) is now available.
Park Ha Biological Technology Co., Ltd. reported a significant increase in total revenue for the six months ended April 30, 2025, reaching $1,239,197, a 45% rise from the previous year. The company’s growth was driven by both product sales and franchise fees, with a notable expansion in its franchise network across various provinces in China. Despite a decrease in the number of franchisees from 43 to 39, the company maintained a robust commercial network. However, the company faces challenges in maintaining brand recognition and adapting to rapid technological changes in the beauty industry, which could impact its operations and financial performance.
More about Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. operates in the beauty industry, focusing on skincare and cosmetic products under the ‘Park Ha’ brand in China. The company develops proprietary beauty products and offers after-sales beauty services through its physical stores and franchise network. Its revenue streams include product sales and franchise fees, with a significant emphasis on expanding market penetration and geographical reach.
Average Trading Volume: 1,607,815
Technical Sentiment Signal: Strong Sell
Learn more about PHH stock on TipRanks’ Stock Analysis page.